MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway

被引:56
|
作者
Hagiwara, Shinji [1 ,2 ]
McClelland, Aaron [1 ]
Kantharidis, Phillip [1 ]
机构
[1] Baker IDI Heart & Diabet Inst, JDRF Danielle Alberti Mem Ctr Diabet Complicat, Diabet Div, Melbourne, Vic 3004, Australia
[2] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo 1138421, Japan
关键词
CHRONIC KIDNEY-DISEASE; GENE-EXPRESSION; MIR-200; FAMILY; MESENCHYMAL TRANSITION; UNCOUPLING PROTEIN-2; CELL-PROLIFERATION; HYPERTENSIVE-RATS; REPRESSORS ZEB1; NADPH OXIDASE; UP-REGULATION;
D O I
10.1155/2013/173783
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MicroRNAs (miRNA) are a novel class of small, noncoding RNA molecules that have gained the attention of many researchers in recent years due to their ability to posttranscriptionally regulate the expression of families of genes simultaneously. Their role in normal physiology and pathobiology is intriguing and their regulation in normal and disease states is fascinating. That the cells can return to a state of homeostasis when these small molecules are perturbed is truly remarkable given the multiple cellular targets of each miRNA and that many mRNAs are targeted by multiple miRNAs. Several reviews have covered aspects of miRNA function in biology and disease. Here, we review the role of miRNA in regulating the renin-angiotensin system, AGE/ RAGE signalling, and under conditions of oxidative stress in the context of diabetic nephropathy.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Diabetic nephropathy: Is there a role for oxidative stress?
    Sagoo, Manpreet K.
    Gnudi, Luigi
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 116 : 50 - 63
  • [32] Role of oxidative stress in diabetic nephropathy
    Vasavada, N
    Agarwal, R
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (02) : 146 - 154
  • [33] Radix Rehmanniae and Corni Fructus against Diabetic Nephropathy via AGE-RAGE Signaling Pathway
    Chen, Jing
    Chen, Yuping
    Shu, Anmei
    Lu, Jinfu
    Du, Qiu
    Yang, Yuwei
    Lv, Zhiyang
    Xu, Huiqin
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [34] Oxidative stress and cellular stress response in diabetic nephropathy
    Calabrese, Vittorio
    Mancuso, Cesare
    Sapienza, Maria
    Puleo, Eduardo
    Calafato, Stella
    Cornelius, Carolin
    Finocchiaro, Manuela
    Mangiameli, Andrea
    Di Mauro, Maurizio
    Stella, Anna Maria Giuffrida
    Castellin, Pietro
    CELL STRESS & CHAPERONES, 2007, 12 (04): : 299 - 306
  • [35] Angiotensin-converting enzyme inhibition in diabetic nephropathy: It's all the RAGE
    Harris, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (08): : 2251 - 2253
  • [36] An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy
    García-Donaire, JA
    Segura, J
    Ruilope, LM
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (09) : 1587 - 1596
  • [37] Dual blockade of the renin–angiotensin–aldosterone system in patients with diabetic nephropathy
    Yolanda E Bogaert
    Nature Clinical Practice Nephrology, 2007, 3 : 532 - 533
  • [38] Dual Renin-Angiotensin-Aldosterone System Block in diabetic Nephropathy
    Pavlicek, V.
    DIABETOLOGE, 2014, 10 (01): : 66 - 67
  • [39] Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension
    Ringel, J
    Beige, J
    Kunz, R
    Distler, A
    Sharma, AM
    DIABETOLOGIA, 1997, 40 (02) : 193 - 199
  • [40] Maximum doses of renin-angiotensin axis blockers in diabetic nephropathy?
    Perez-Monteoliva, Nicolas Roberto Robles
    Lorido, Jose Carlos Arevalo
    MEDICINA CLINICA, 2021, 157 (01): : 20 - 21